MARKETS PERPS LIVE53

Cash

Trending Elections Politics Culture Sports Crypto Commodities Climate Economics Mentions Finance Tech & Science

Predict Live53 AccountSocial

Product

Perpetual Futures Markets Incentive program Institutions API & developers

Company

About Kalshi Research Blog Careers Policy Center Brand Kit

Help

Help Center FAQ Fee schedule Trading hours Regulatory Trust Center

© 2026 Kalshi Inc. · All rights reserved

Privacy Data Terms of Service Trading Prohibitions FAQ for Finance Professionals

Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.

Trending Elections Politics Culture Sports Crypto Commodities Climate Economics Mentions Finance Tech & Science

Hims & Hers Health

HIMS

ReportsAug 10, 2026 · time not confirmed

Fiscal periodNot stated

Market cap$6.71B

Consensus EPSNot covered · 3 estimates

Year-ago EPSNot available

Expected changeNot available

Quarterly markets

What will Hims say during their next earnings call?

Cancer
100%
Regulation
100%
Amazon
100%
Peptide
100%
FDA
100%
Tariff
100%
Testosterone
100%
Collaboration
100%
Canada
100%
Europe
100%
Zava
100%
Lab Testing
100%

7 more words trade on this call

Q2 Subscribers

Open interest16Volume144Trade

Full year

Subscribers

Open interest0Volume66Trade

Most likely range

Over 3.04100%

Market average3.06

Implied by 15 contracts across the subscribers ladder.

Most likely range

Over 3.2M100%

Market average3,200,000

Implied by 11 contracts across the subscribers ladder.